Variant report

Variant	nsv602864
Chromosome Location	chr6:34203406-34204532
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:689)
CpG islands
(count:307)
Chromatin interactive
region (count:45)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:689 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:34204026-34204141	HepG2	liver:	n/a	n/a
2	ARID3A	chr6:34203901-34204096	K562	blood:	n/a	n/a
3	ATF2	chr6:34203276-34204643	H1-hESC	embryonic stem cell:	n/a	n/a
4	ATF2	chr6:34203212-34204748	H1-hESC	embryonic stem cell:	n/a	n/a
5	ATF2	chr6:34204275-34204601	GM12878	blood:	n/a	n/a
6	ATF2	chr6:34203931-34205103	GM12878	blood:	n/a	n/a
7	ATF2	chr6:34203884-34204262	GM12878	blood:	n/a	n/a
8	ATF3	chr6:34204228-34204739	K562	blood:	n/a	chr6:34204588-34204597
9	ATF3	chr6:34203296-34203735	K562	blood:	n/a	n/a
10	BACH1	chr6:34202422-34204707	H1-hESC	embryonic stem cell:	n/a	chr6:34203549-34203563
11	BACH1	chr6:34203470-34204683	K562	blood:	n/a	chr6:34203549-34203563
12	BATF	chr6:34204030-34204219	GM12878	blood:	n/a	chr6:34204065-34204073
13	BATF	chr6:34204281-34204556	GM12878	blood:	n/a	n/a
14	BCL11A	chr6:34204248-34204585	GM12878	blood:	n/a	n/a
15	BCL3	chr6:34203373-34203712	A549	lung:	n/a	chr6:34203414-34203427 chr6:34203434-34203443
16	BCL3	chr6:34204235-34205090	GM12878	blood:	n/a	chr6:34204938-34204947 chr6:34204935-34204944 chr6:34204934-34204947
17	BCL3	chr6:34203369-34204260	K562	blood:	n/a	chr6:34203414-34203427 chr6:34203434-34203443
18	BCLAF1	chr6:34203355-34204135	K562	blood:	n/a	chr6:34203414-34203427 chr6:34203434-34203443
19	BCLAF1	chr6:34203209-34205104	K562	blood:	n/a	chr6:34204938-34204947 chr6:34203272-34203281 chr6:34203414-34203427 chr6:34203434-34203443 chr6:34204935-34204944 chr6:34204934-34204947
20	BCLAF1	chr6:34203716-34204767	GM12878	blood:	n/a	n/a
21	BCLAF1	chr6:34203336-34205094	GM12878	blood:	n/a	chr6:34204938-34204947 chr6:34203414-34203427 chr6:34203434-34203443 chr6:34204935-34204944 chr6:34204934-34204947
22	BHLHE40	chr6:34203081-34204903	K562	blood:	n/a	chr6:34204607-34204623
23	BHLHE40	chr6:34204417-34204945	HepG2	liver:	n/a	chr6:34204607-34204623 chr6:34204910-34204926
24	BHLHE40	chr6:34203289-34203573	A549	lung:	n/a	n/a
25	BHLHE40	chr6:34203088-34205165	GM12878	blood:	n/a	chr6:34204607-34204623 chr6:34204910-34204926
26	BRCA1	chr6:34204348-34204764	Hela-S3	cervix:	n/a	n/a
27	BRCA1	chr6:34204293-34204485	HepG2	liver:	n/a	n/a
28	BRCA1	chr6:34203510-34203773	Hela-S3	cervix:	n/a	n/a
29	BRCA1	chr6:34203804-34204119	H1-hESC	embryonic stem cell:	n/a	n/a
30	CBX3	chr6:34202931-34204843	K562	blood:	n/a	n/a
31	CBX3	chr6:34204274-34204560	K562	blood:	n/a	n/a
32	CBX3	chr6:34203639-34204160	K562	blood:	n/a	n/a
33	CCNT2	chr6:34202690-34206370	K562	blood:	n/a	chr6:34202983-34202992 chr6:34204588-34204597 chr6:34203018-34203027 chr6:34203362-34203371 chr6:34205365-34205374 chr6:34205687-34205696 chr6:34203060-34203069 chr6:34204858-34204867 chr6:34205495-34205504 chr6:34203273-34203282
34	CEBPB	chr6:34203843-34204274	K562	blood:	n/a	chr6:34203984-34203992
35	CEBPB	chr6:34204185-34204635	GM12878	blood:	n/a	n/a
36	CEBPB	chr6:34203415-34204271	Hela-S3	cervix:	n/a	chr6:34203984-34203992
37	CEBPB	chr6:34203892-34204254	A549	lung:	n/a	chr6:34203984-34203992
38	CEBPB	chr6:34203371-34204547	K562	blood:	n/a	chr6:34203984-34203992
39	CEBPB	chr6:34203913-34204243	HepG2	liver:	n/a	chr6:34203984-34203992
40	CEBPB	chr6:34203558-34203641	K562	blood:	n/a	n/a
41	CEBPB	chr6:34203140-34203647	H1-hESC	embryonic stem cell:	n/a	n/a
42	CEBPB	chr6:34203442-34204245	IMR90	lung:	n/a	chr6:34203984-34203992
43	CEBPB	chr6:34203923-34204259	H1-hESC	embryonic stem cell:	n/a	chr6:34203984-34203992
44	CEBPD	chr6:34203055-34205004	K562	blood:	n/a	n/a
45	CEBPD	chr6:34204187-34204879	HepG2	liver:	n/a	n/a
46	CEBPD	chr6:34203221-34204925	K562	blood:	n/a	n/a
47	CHD1	chr6:34203402-34205116	H1-hESC	embryonic stem cell:	n/a	chr6:34203477-34203487
48	CHD1	chr6:34203247-34207472	IMR90	lung:	n/a	chr6:34205496-34205506 chr6:34205433-34205443 chr6:34203477-34203487 chr6:34205352-34205359
49	CHD1	chr6:34203488-34205101	GM12878	blood:	n/a	n/a
50	CHD2	chr6:34202784-34204760	K562	blood:	n/a	chr6:34203149-34203159 chr6:34203477-34203487

(count:307 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:34203887-34203937	MCF-7	breast:	n/a
2	chr6:34203887-34203937	BE2_C	brain:	n/a
3	chr6:34203887-34203937	MCF-7	breast:	n/a
4	chr6:34203887-34203937	BE2_C	brain:	n/a
5	chr6:34204304-34204354	IMR90	lung:	fetal
6	chr6:34203887-34203937	IMR90	lung:	fetal
7	chr6:34203564-34203614	SAEC	small airway:	n/a
8	chr6:34203887-34203937	BJ	skin:	n/a
9	chr6:34203630-34203680	HL-60	blood:	n/a
10	chr6:34204304-34204354	CMK	blood:	n/a
11	chr6:34204459-34204509	ECC-1	luminal epithelium:	n/a
12	chr6:34203564-34203614	HRPEpiC	eye:	n/a
13	chr6:34203887-34203937	HRPEpiC	eye:	n/a
14	chr6:34204459-34204509	CMK	blood:	n/a
15	chr6:34203630-34203680	HIPEpiC	eye:	n/a
16	chr6:34203630-34203680	Hepatocyte	liver:	n/a
17	chr6:34203564-34203614	LNCaP	prostate:	n/a
18	chr6:34203564-34203614	SK-N-SH_RA	brain:	n/a
19	chr6:34204459-34204509	HCT-116	colon:	n/a
20	chr6:34203630-34203680	ovcar-3	ovarian:	n/a
21	chr6:34203564-34203614	AG10803	skin:	n/a
22	chr6:34204304-34204354	MCF10A-Er-Src	breast:	n/a
23	chr6:34204459-34204509	NH-A	brain:	n/a
24	chr6:34203887-34203937	AoSMC	blood vessel:	n/a
25	chr6:34204304-34204354	NB4	blood:	n/a
26	chr6:34203630-34203680	GM19239	blood:	n/a
27	chr6:34204459-34204509	SK-N-SH	brain:	n/a
28	chr6:34204459-34204509	NHBE	bronchial:	n/a
29	chr6:34204459-34204509	SKMC	muscle:	n/a
30	chr6:34204459-34204509	PFSK-1	brain:	n/a
31	chr6:34204304-34204354	HMEC	breast:	n/a
32	chr6:34203887-34203937	RPTEC	kidney:	n/a
33	chr6:34203887-34203937	HAEpiC	amniotic membrane:	n/a
34	chr6:34204304-34204354	BJ	skin:	n/a
35	chr6:34203630-34203680	ECC-1	luminal epithelium:	n/a
36	chr6:34203630-34203680	AG10803	skin:	n/a
37	chr6:34203887-34203937	HEEpiC	esophagus:	n/a
38	chr6:34203564-34203614	NHDF-neo	bronchial:	n/a
39	chr6:34203630-34203680	HCPEpiC	choroid plexus:	n/a
40	chr6:34203564-34203614	HIPEpiC	eye:	n/a
41	chr6:34204304-34204354	GM12878	blood:	n/a
42	chr6:34203564-34203614	U87	brain:	n/a
43	chr6:34203564-34203614	ProgFib	skin:	n/a
44	chr6:34203887-34203937	HIPEpiC	eye:	n/a
45	chr6:34203564-34203614	K562	blood:	n/a
46	chr6:34204459-34204509	NT2-D1	testis:	n/a
47	chr6:34204459-34204509	NB4	blood:	n/a
48	chr6:34204459-34204509	NHDF-neo	bronchial:	n/a
49	chr6:34203630-34203680	HAEpiC	amniotic membrane:	n/a
50	chr6:34204304-34204354	GM19239	blood:	n/a

(count:45 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:34204158..34206160-chr6:34249084..34250799,2	K562	blood:
2	chr15:78730134..78730654-chr6:34204413..34205121,2	Hela-S3	cervix:
3	chr6:34202333..34204420-chr6:34346794..34349148,2	K562	blood:
4	chr6:34201904..34204640-chr6:34398634..34402211,3	K562	blood:
5	chr6:34203866..34208750-chr6:34388488..34394053,10	MCF-7	breast:
6	chr6:34202422..34206409-chr6:34359682..34362061,4	MCF-7	breast:
7	chr1:145611150..145611650-chr6:34204399..34204900,2	Hela-S3	cervix:
8	chr3:52017009..52017769-chr6:34203221..34204195,2	Hela-S3	cervix:
9	chr6:32939896..32942243-chr6:34202585..34204574,3	K562	blood:
10	chr3:156392161..156392699-chr6:34204120..34204941,2	Hela-S3	cervix:
11	chr11:62609122..62609720-chr6:34204185..34204725,2	Hela-S3	cervix:
12	chr6:34201904..34204640-chr6:34398022..34401494,3	K562	blood:
13	chr6:27114807..27116319-chr6:34202953..34205471,2	K562	blood:
14	chr6:34201303..34203546-chr6:34292849..34294793,2	K562	blood:
15	chr11:33061352..33062092-chr6:34204110..34205009,2	Hela-S3	cervix:
16	chr6:34202383..34217863-chr6:34357259..34364960,37	K562	blood:
17	chr6:34128401..34131565-chr6:34200837..34203571,3	K562	blood:
18	chr6:34199984..34203528-chr6:34381840..34383462,3	K562	blood:
19	chr6:34202622..34206817-chr6:34391790..34393979,3	MCF-7	breast:
20	chr6:34204142..34204871-chr8:145734847..145735360,2	HCT-116	colon:
21	chr6:33383299..33386120-chr6:34202398..34204899,2	K562	blood:
22	chr6:34203686..34207490-chr6:34388234..34395019,9	K562	blood:
23	chr6:34203584..34206226-chr6:34392090..34394590,2	K562	blood:
24	chr6:34202035..34203669-chr6:34568608..34571560,2	K562	blood:
25	chr6:34202852..34208935-chr6:34358420..34361531,11	K562	blood:
26	chr6:34129957..34135547-chr6:34199905..34204260,7	K562	blood:
27	chr6:34204127..34204964-chr9:131790137..131790828,2	Hela-S3	cervix:
28	chr1:249120210..249121150-chr6:34204127..34204729,2	Hela-S3	cervix:
29	chr6:34203144..34206658-chr6:34358641..34361602,5	MCF-7	breast:
30	chr6:34200572..34203532-chr6:34391693..34395651,4	K562	blood:
31	chr22:42371294..42372795-chr6:34203726..34205755,2	K562	blood:
32	chr6:34202035..34205684-chr6:35227191..35229008,3	K562	blood:
33	chr6:34202426..34206348-chr6:34246132..34251181,8	K562	blood:
34	chr6:33587172..33590152-chr6:34203876..34205466,2	K562	blood:
35	chr17:73775389..73776032-chr6:34203614..34204246,2	Hela-S3	cervix:
36	chr6:32937897..32939542-chr6:34204390..34205971,2	K562	blood:
37	chr6:26030302..26034233-chr6:34203696..34206879,3	K562	blood:
38	chr6:32935087..32937260-chr6:34203527..34205699,2	K562	blood:
39	chr6:34204520..34207436-chr6:34522666..34524361,2	K562	blood:
40	chr15:79164841..79165710-chr6:34204367..34204927,2	HCT-116	colon:
41	chr13:111365203..111365774-chr6:34203417..34204256,2	Hela-S3	cervix:
42	chr6:34204437..34204948-chr9:100745047..100745884,2	HCT-116	colon:
43	chr6:34204016..34204516-chr6:86353287..86353909,2	Hela-S3	cervix:
44	chr20:43973655..43975022-chr6:34203627..34204195,3	Hela-S3	cervix:
45	chr6:34200640..34204018-chr6:34638884..34642541,3	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-HMGA1-1	chr6:34203398-34203606	XLOC_005264
2	lnc-HMGA1-1	chr6:34203881-34204471	XLOC_005264

No data

Variant related genes	Relation type
HMGA1	TF binding region
HMGA1	CpG island
ENSG00000100167	chromatin interactions
ENSG00000065029	chromatin interactions
ENSG00000135316	chromatin interactions
ENSG00000265565	chromatin interactions
ENSG00000136938	chromatin interactions
ENSG00000136381	chromatin interactions
ENSG00000225339	chromatin interactions
ENSG00000132475	chromatin interactions
ENSG00000264500	chromatin interactions
ENSG00000184825	chromatin interactions
ENSG00000196821	chromatin interactions
ENSG00000167700	chromatin interactions
ENSG00000112514	chromatin interactions
ENSG00000124693	chromatin interactions
ENSG00000124664	chromatin interactions
ENSG00000121848	chromatin interactions
ENSG00000133316	chromatin interactions
ENSG00000263756	chromatin interactions
ENSG00000185787	chromatin interactions
ENSG00000223837	chromatin interactions
ENSG00000243926	chromatin interactions
ENSG00000204257	chromatin interactions
ENSG00000096433	chromatin interactions
ENSG00000243989	chromatin interactions
ENSG00000163659	chromatin interactions
ENSG00000270800	chromatin interactions
ENSG00000153487	chromatin interactions
ENSG00000114779	chromatin interactions
ENSG00000124614	chromatin interactions
ENSG00000204256	chromatin interactions
ENSG00000175137	chromatin interactions
ENSG00000176148	chromatin interactions
ENSG00000148341	chromatin interactions
ENSG00000137259	chromatin interactions
ENSG00000272325	chromatin interactions

Extended variants
information (count: 70 )
Associated
traits (count: 105 )

Variant overlapped rSNPs/rCNVs (count:70 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs34052020	chr6:34203406-34203407	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region lncRNA	14 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs560885144	chr6:34203443-34203444	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region lncRNA	15 gene(s)	Overlapped CNVs	n/a
3	rs576068503	chr6:34203446-34203447	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region lncRNA	15 gene(s)	Overlapped CNVs	n/a
4	rs543546178	chr6:34203463-34203464	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region lncRNA	15 gene(s)	Overlapped CNVs	n/a
5	rs537388306	chr6:34203470-34203471	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region lncRNA	15 gene(s)	Overlapped CNVs	n/a
6	rs532371394	chr6:34203491-34203492	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region lncRNA	15 gene(s)	Overlapped CNVs	n/a
7	rs192265356	chr6:34203526-34203527	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region lncRNA	15 gene(s)	Overlapped CNVs	n/a
8	rs559471120	chr6:34203531-34203532	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region lncRNA	16 gene(s)	Overlapped CNVs	n/a
9	rs529951985	chr6:34203632-34203633	Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region	17 gene(s)	Overlapped CNVs	n/a
10	rs548038472	chr6:34203658-34203659	Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region	17 gene(s)	Overlapped CNVs	n/a
11	rs567322548	chr6:34203676-34203677	Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region	17 gene(s)	Overlapped CNVs	n/a
12	rs537844110	chr6:34203722-34203723	Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	19 gene(s)	Overlapped CNVs	n/a
13	rs115175766	chr6:34203751-34203752	Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	20 gene(s)	Overlapped CNVs	n/a
14	rs571637770	chr6:34203787-34203788	Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	20 gene(s)	Overlapped CNVs	n/a
15	rs539252494	chr6:34203820-34203821	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region	20 gene(s)	Overlapped CNVs	n/a
16	rs144206074	chr6:34203884-34203885	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	21 gene(s)	Overlapped CNVs	n/a
17	rs115177000	chr6:34203893-34203894	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription	TF binding region CpG island Chromatin interactive region lncRNA	21 gene(s)	Overlapped CNVs	n/a
18	rs556891505	chr6:34203919-34203920	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription	TF binding region CpG island Chromatin interactive region lncRNA	21 gene(s)	Overlapped CNVs	n/a
19	rs555255269	chr6:34203924-34203925	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription	TF binding region CpG island Chromatin interactive region lncRNA	21 gene(s)	Overlapped CNVs	n/a
20	rs576154264	chr6:34203949-34203950	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	21 gene(s)	Overlapped CNVs	n/a
21	rs554553791	chr6:34203982-34203983	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	21 gene(s)	Overlapped CNVs	n/a
22	rs543035078	chr6:34203983-34203984	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	21 gene(s)	Overlapped CNVs	n/a
23	rs565019600	chr6:34204003-34204004	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	21 gene(s)	Overlapped CNVs	n/a
24	rs576885820	chr6:34204029-34204030	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	21 gene(s)	Overlapped CNVs	n/a
25	rs565054432	chr6:34204037-34204038	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	21 gene(s)	Overlapped CNVs	n/a
26	rs375217712	chr6:34204039-34204040	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	21 gene(s)	Overlapped CNVs	n/a
27	rs28365876	chr6:34204063-34204064	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	21 gene(s)	Overlapped CNVs	n/a
28	rs529789953	chr6:34204086-34204087	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	21 gene(s)	Overlapped CNVs	n/a
29	rs139783931	chr6:34204088-34204089	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	21 gene(s)	Overlapped CNVs	n/a
30	rs149923876	chr6:34204089-34204090	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	21 gene(s)	Overlapped CNVs	n/a
31	rs9469747	chr6:34204110-34204111	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	22 gene(s)	Overlapped CNVs	n/a
32	rs183867431	chr6:34204140-34204141	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	27 gene(s)	Overlapped CNVs	n/a
33	rs188870485	chr6:34204159-34204160	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	28 gene(s)	Overlapped CNVs	n/a
34	rs538774319	chr6:34204163-34204164	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	28 gene(s)	Overlapped CNVs	n/a
35	rs193114449	chr6:34204167-34204168	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	28 gene(s)	Overlapped CNVs	n/a
36	rs145017319	chr6:34204171-34204172	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	28 gene(s)	Overlapped CNVs	n/a
37	rs536836568	chr6:34204180-34204181	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	28 gene(s)	Overlapped CNVs	n/a
38	rs2780225	chr6:34204183-34204184	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	28 gene(s)	Overlapped CNVs	n/a
39	rs184337879	chr6:34204191-34204192	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	29 gene(s)	Overlapped CNVs	n/a
40	rs189282057	chr6:34204199-34204200	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	27 gene(s)	Overlapped CNVs	n/a
41	rs28365877	chr6:34204222-34204223	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	27 gene(s)	Overlapped CNVs	n/a
42	rs558281881	chr6:34204225-34204226	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	27 gene(s)	Overlapped CNVs	n/a
43	rs530121687	chr6:34204235-34204236	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	27 gene(s)	Overlapped CNVs	n/a
44	rs573333851	chr6:34204260-34204261	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	25 gene(s)	Overlapped CNVs	n/a
45	rs540770290	chr6:34204262-34204263	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	25 gene(s)	Overlapped CNVs	n/a
46	rs370777002	chr6:34204283-34204284	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	25 gene(s)	Overlapped CNVs	n/a
47	rs6937622	chr6:34204285-34204286	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	25 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs191720756	chr6:34204286-34204287	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	25 gene(s)	Overlapped CNVs	n/a
49	rs541606678	chr6:34204287-34204288	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region Chromatin interactive region lncRNA	25 gene(s)	Overlapped CNVs	n/a
50	rs114677490	chr6:34204304-34204305	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Weak transcription	TF binding region CpG island Chromatin interactive region lncRNA	25 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:105)

Disease	PMID	Source
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Melanoma	18172304	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Hepatocellular carcinoma	16750200	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	16397240	CNVD
Retinoblastoma	22278416	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Systemic lupus erythematosus	20877625	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Systemic lupus erythematosus	19279649	CNVD
Retinoblastoma	16790693	CNVD
Acute myocardial infarction	18032375	CNVD
Renal cell carcinoma	19150565	CNVD
Systemic lupus erythematosus	19591781	CNVD
Attention deficit hyperactivity disorder	19287146	CNVD
Autism	19287146	CNVD
Erythema nodosum in leprosy	19287146	CNVD
Henoch-schoenlein purpura	19287146	CNVD
Liver cirrhosis	19287146	CNVD
Systemic lupus erythematosus	19287146	CNVD
Autoimmune disease	19135723	CNVD
Congenital adrenal hyperplasia	18478071	CNVD
Systemic lupus erythematosus	19287147	CNVD
Osteosarcoma	16790693	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Cancer	22183965	CNVD
Melanoma	22183965	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Lung cancer	18438408	CNVD
Glioblastoma multiforme	21138945	CNVD
Breast cancer	21364760	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Myelofibrosis	22110671	CNVD
Liver carcinoma	19366792	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Schizophrenia	23813976	CNVD

Chromatin state (count:255 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:34192400-34203600	Weak transcription	Placenta Amnion	Placenta Amnion
2	chr6:34192600-34203600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
3	chr6:34192600-34204400	Weak transcription	HSMMtube	muscle
4	chr6:34192800-34203800	Weak transcription	Skeletal Muscle Female	skeletal muscle
5	chr6:34194800-34203600	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
6	chr6:34195800-34203600	Weak transcription	Spleen	Spleen
7	chr6:34197400-34203600	Weak transcription	NHLF	lung
8	chr6:34199000-34203800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
9	chr6:34199600-34203600	Weak transcription	Brain Anterior Caudate	brain
10	chr6:34201200-34203800	Weak transcription	NHDF-Ad	bronchial
11	chr6:34201200-34203800	Weak transcription	Osteobl	bone
12	chr6:34201200-34204200	Weak transcription	HSMM	muscle
13	chr6:34201800-34203800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
14	chr6:34202000-34203800	Weak transcription	Brain Substantia Nigra	brain
15	chr6:34202400-34203800	Enhancers	Primary hematopoietic stem cells	blood
16	chr6:34202400-34207000	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
17	chr6:34202400-34207400	Active TSS	H9 Cell Line	embryonic stem cell
18	chr6:34202400-34207400	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
19	chr6:34202600-34203600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
20	chr6:34202600-34203600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
21	chr6:34202600-34203600	Enhancers	Lung	lung
22	chr6:34202600-34206000	Active TSS	HUES64 Cell Line	embryonic stem cell
23	chr6:34202600-34206000	Active TSS	iPS-18 Cell Line	embryonic stem cell
24	chr6:34202600-34206200	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
25	chr6:34202600-34206200	Active TSS	iPS-15b Cell Line	embryonic stem cell
26	chr6:34202600-34206800	Active TSS	ES-I3 Cell Line	embryonic stem cell
27	chr6:34202800-34203600	Active TSS	Fetal Intestine Small	intestine
28	chr6:34202800-34203600	Enhancers	Placenta	Placenta
29	chr6:34202800-34206000	Active TSS	H1 Cell Line	embryonic stem cell
30	chr6:34202800-34206000	Active TSS	Thymus	Thymus
31	chr6:34202800-34206200	Active TSS	iPS-20b Cell Line	embryonic stem cell
32	chr6:34202800-34206400	Active TSS	HUES48 Cell Line	embryonic stem cell
33	chr6:34202800-34206800	Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
34	chr6:34202800-34206800	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
35	chr6:34202800-34206800	Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
36	chr6:34203000-34203600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
37	chr6:34203000-34203600	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
38	chr6:34203000-34203800	Active TSS	HUES6 Cell Line	embryonic stem cell
39	chr6:34203000-34203800	Active TSS	Primary T helper naive cells fromperipheralblood	blood
40	chr6:34203000-34204600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
41	chr6:34203000-34205400	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
42	chr6:34203200-34204400	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
43	chr6:34203200-34205400	Active TSS	Primary mononuclear cells fromperipheralblood	Blood
44	chr6:34203200-34206200	Active TSS	Sigmoid Colon	Sigmoid Colon
45	chr6:34203200-34206400	Active TSS	Small Intestine	intestine
46	chr6:34203400-34203600	Enhancers	Primary monocytes fromperipheralblood	blood
47	chr6:34203400-34203600	Enhancers	Primary T cells from cord blood	blood
48	chr6:34203400-34203600	Active TSS	Primary T helper cells PMA-I stimulated	--
49	chr6:34203400-34203600	Active TSS	Primary T helper 17 cells PMA-I stimulated	--
50	chr6:34203400-34203600	Active TSS	Brain Hippocampus Middle	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links